Vimta Labs Limited (VIMTALABS) fundamentals
Vimta Labs Limited is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as VIMTALABS (ISIN INE579C01029). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Vimta Labs Limited does
Vimta Labs Limited is contract research and testing services provider in India. The Company operates through the Contract Research and Testing Services segment. It is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include drug discovery, development, and drug life cycle management support services; preclinical research and testing services for medical device companies; contract research and testing for agrochemical and specialty chemical companies; food testing and analytical development services to support manufacturers, processors, farmers, and retailers; and environmental regulatory services, such as impact assessments and post project monitoring to various industries, such as power, infrastructure, and others.
Valuation and market data
| Last close | ₹629.60 |
|---|---|
| Market capitalisation | ₹2,805 crore |
| Enterprise value | ₹2,821 crore |
| P/E (TTM) | 36.18 |
| Price to book | 6.14 |
| Price to sales (TTM) | 3.87 |
| Book value per share | ₹102.56 |
| Dividend yield | 31.77% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Thu Dec 15 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹416 crore | ₹104 crore | ₹78 crore | 17.40 |
| Mar 2025 | ₹348 crore | ₹89 crore | ₹67 crore | 30.28 |
| Mar 2024 | ₹292 crore | ₹63 crore | ₹49 crore | 18.51 |
| Mar 2023 | ₹319 crore | ₹64 crore | ₹47 crore | 21.37 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 35.7% |
|---|---|
| Foreign institutions (FII) | 4.4% |
| Mutual funds | 0.2% |
| Other domestic institutions | 0.2% |
| Retail and others | 59.5% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.